"Un établissement de référence pour le traitement du cancer par radiothérapie et chimiothérapie dans un cadre médical et technologique de pointe, avec des procédures de travail rigoureuses appliquées en routine quotidienne. Depuis 2016, le centre a rejoint Amethyst. La volonté de la nouvelle équipe est de moderniser le matériel en dotant le centre d’un accélérateur de nouvelle génération assurant ainsi une prise en charge adaptée et orientée sur l’efficacité, de logiciels de calcul récents, du matériel de dosimétrie et du matériel de contention permettant le plus grand confort du patient et un repositionnement plus précis."

During the past decade, Centre Gray conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Gray" #1 collaborator was "Aix Marseille Université" with 1 trials as a collaborator, "Canceropôle Nord Ouest" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Gray" are "Rectal Cancer" (2 trials), "Aging" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Epidermoid Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Centre Gray" in a lesser frequency.

Most popular intervention types in "Centre Gray" are "Drug" (6 trials), "Radiation" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (2 trials), "radiation therapy" (2 trials), "Cetuximab" (1 trials), "Delivery of questionnaires" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Gray" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centre Gray". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre Gray, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Gray, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".